These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2324368)

  • 1. Compression in the treatment of leg telangiectasia: a preliminary report.
    Goldman MP; Beaudoing D; Marley W; Lopez L; Butie A
    J Dermatol Surg Oncol; 1990 Apr; 16(4):322-5. PubMed ID: 2324368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sclerotherapy of varicose and telangiectatic leg veins. Minimal sclerosant concentration of hypertonic saline and its relationship to vessel diameter.
    Sadick NS
    J Dermatol Surg Oncol; 1991 Jan; 17(1):65-70. PubMed ID: 1991883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulsed-dye laser treatment of leg telangiectasia: with and without simultaneous sclerotherapy.
    Goldman MP; Fitzpatrick RE
    J Dermatol Surg Oncol; 1990 Apr; 16(4):338-44. PubMed ID: 2324370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resolution of pain associated with varicose and telangiectatic leg veins after compression sclerotherapy.
    Weiss RA; Weiss MA
    J Dermatol Surg Oncol; 1990 Apr; 16(4):333-6. PubMed ID: 2324369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. My sclerotherapy technique for telangiectasia and reticular veins.
    Goldman MP
    Dermatol Surg; 2010 Jun; 36 Suppl 2():1040-5. PubMed ID: 20590711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines of care for sclerotherapy treatment of varicose and telangiectatic leg veins. American Academy of Dermatology.
    J Am Acad Dermatol; 1996 Mar; 34(3):523-8. PubMed ID: 8609276
    [No Abstract]   [Full Text] [Related]  

  • 7. Postsclerotherapy hyperpigmentations. Chromated glycerin as a screen for patients at risk (a retrospective study).
    Georgiev M
    J Dermatol Surg Oncol; 1993 Jul; 19(7):649-52. PubMed ID: 8349903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consensus for sclerotherapy.
    Weiss MA; Hsu JT; Neuhaus I; Sadick NS; Duffy DM
    Dermatol Surg; 2014 Dec; 40(12):1309-18. PubMed ID: 25418805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of reticular and telangiectatic leg veins: double-blind, prospective comparative trial of polidocanol and hypertonic saline.
    Peterson JD; Goldman MP; Weiss RA; Duffy DM; Fabi SG; Weiss MA; Guiha I
    Dermatol Surg; 2012 Aug; 38(8):1322-30. PubMed ID: 22620717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compression after sclerotherapy for telangiectasias and reticular leg veins: a randomized controlled study.
    Kern P; Ramelet AA; Wütschert R; Hayoz D
    J Vasc Surg; 2007 Jun; 45(6):1212-6. PubMed ID: 17467226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of side effects in the treatment of telangiectasias by compression sclerotherapy: hypertonic saline vs. polidocanol.
    Weiss RA; Weiss MA
    J Dermatol Surg Oncol; 1990 Sep; 16(9):800-4. PubMed ID: 2398199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sclerotherapy in tumescent anesthesia of reticular veins and telangiectasias.
    Ramelet AA
    Dermatol Surg; 2012 May; 38(5):748-51. PubMed ID: 22268802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compression in the treatment of leg telangiectasia: theoretical considerations.
    Goldman MP
    J Dermatol Surg Oncol; 1989 Feb; 15(2):184-8. PubMed ID: 2644328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sclerotherapy of telangiectasias or spider veins in the lower limb: A review.
    Thomson L
    J Vasc Nurs; 2016 Jun; 34(2):61-2. PubMed ID: 27210454
    [No Abstract]   [Full Text] [Related]  

  • 15. How many treatments are necessary to sclerose varicose and telangiectatic leg veins?
    Goldman MP
    J Dermatol Surg Oncol; 1991 Jan; 17(1):62. PubMed ID: 1991882
    [No Abstract]   [Full Text] [Related]  

  • 16. Determination of incidence and risk factors for postsclerotherapy telangiectatic matting of the lower extremity: a retrospective analysis.
    Davis LT; Duffy DM
    J Dermatol Surg Oncol; 1990 Apr; 16(4):327-30. PubMed ID: 1691217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sclerotherapy for varicose and telangiectatic veins.
    Green D
    Am Fam Physician; 1992 Sep; 46(3):827-37. PubMed ID: 1514476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of graduated compression stockings for an additional 3 weeks after sclerotherapy treatment of reticular and telangiectatic leg veins.
    Nootheti PK; Cadag KM; Magpantay A; Goldman MP
    Dermatol Surg; 2009 Jan; 35(1):53-7; discussion 57-8. PubMed ID: 19067733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Local drugs in treating and decreasing the incidence of adverse reactions after sclerotherapy of telangiectasia].
    Bogachev VI; Boldin BV; Turkin PI; Lobanov VN
    Angiol Sosud Khir; 2019; 25(4):102-107. PubMed ID: 31855206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical comparison of sclerotherapy versus long-pulsed Nd:YAG laser treatment for lower extremity telangiectases.
    Lupton JR; Alster TS; Romero P
    Dermatol Surg; 2002 Aug; 28(8):694-7. PubMed ID: 12174060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.